These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28983082)

  • 21. A mechanistic study of enantiomeric separation with vancomycin and balhimycin as chiral selectors by capillary electrophoresis. Dimerization and enantioselectivity.
    Kang J; Bischoff D; Jiang Z; Bister B; Süssmuth RD; Schurig V
    Anal Chem; 2004 Apr; 76(8):2387-92. PubMed ID: 15080752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the DNA-binding site for the phosphorylated VanR protein required for vancomycin resistance in Enterococcus faecium.
    Holman TR; Wu Z; Wanner BL; Walsh CT
    Biochemistry; 1994 Apr; 33(15):4625-31. PubMed ID: 8161518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. vanC cluster of vancomycin-resistant Enterococcus gallinarum BM4174.
    Arias CA; Courvalin P; Reynolds PE
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1660-6. PubMed ID: 10817725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure of VanS from vancomycin-resistant enterococci: A sensor kinase with weak ATP binding.
    Grasty KC; Guzik C; D'Lauro EJ; Padrick SB; Beld J; Loll PJ
    J Biol Chem; 2023 Mar; 299(3):103001. PubMed ID: 36764524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-talk between the histidine protein kinase VanS and the response regulator PhoB. Characterization and identification of a VanS domain that inhibits activation of PhoB.
    Fisher SL; Jiang W; Wanner BL; Walsh CT
    J Biol Chem; 1995 Sep; 270(39):23143-9. PubMed ID: 7559459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic comparison of the specificity of the vancomycin resistance VanSfor two response regulators, VanR and PhoB.
    Fisher SL; Kim SK; Wanner BL; Walsh CT
    Biochemistry; 1996 Apr; 35(15):4732-40. PubMed ID: 8664263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A vancomycin-dependent VanA-type Enterococcus faecalis strain isolated in Japan from chicken imported from China.
    Tanimoto K; Nomura T; Hamatani H; Xiao YH; Ike Y
    Lett Appl Microbiol; 2005; 41(2):157-62. PubMed ID: 16033514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor.
    Koteva K; Hong HJ; Wang XD; Nazi I; Hughes D; Naldrett MJ; Buttner MJ; Wright GD
    Nat Chem Biol; 2010 May; 6(5):327-9. PubMed ID: 20383152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calculation of concentrations of equilibrium components in an in vitro activity test of vancomycin antibiotics and the possible mode of action.
    Yan H; Cheng X; He B
    Biophys Chem; 1998 Aug; 74(2):107-15. PubMed ID: 9760722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vancomycin: ligand recognition, dimerization and super-complex formation.
    Jia Z; O'Mara ML; Zuegg J; Cooper MA; Mark AE
    FEBS J; 2013 Mar; 280(5):1294-307. PubMed ID: 23298227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A ligand-mediated dimerization mode for vancomycin.
    Loll PJ; Miller R; Weeks CM; Axelsen PH
    Chem Biol; 1998 May; 5(5):293-8. PubMed ID: 9578636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal heterogeneity of clinical isolates of vancomycin-resistant Enterococcus faecium with unique vanS.
    Pourshafie MR; Talebi M; Saifi M; Katouli M; Eshraghi S; Kühn I; Möllby R
    Trop Med Int Health; 2008 May; 13(5):722-7. PubMed ID: 18373511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis.
    Depardieu F; Kolbert M; Pruul H; Bell J; Courvalin P
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3892-904. PubMed ID: 15388450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147.
    Arthur M; Molinas C; Courvalin P
    J Bacteriol; 1992 Apr; 174(8):2582-91. PubMed ID: 1556077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An analysis of the origins of a cooperative binding energy of dimerization.
    Williams DH; Maguire AJ; Tsuzuki W; Westwell MS
    Science; 1998 May; 280(5364):711-4. PubMed ID: 9563941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New combinations of mutations in VanD-Type vancomycin-resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium strains.
    Depardieu F; Foucault ML; Bell J; Dubouix A; Guibert M; Lavigne JP; Levast M; Courvalin P
    Antimicrob Agents Chemother; 2009 May; 53(5):1952-63. PubMed ID: 19258279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial resistance (AMR) nanomachines-mechanisms for fluoroquinolone and glycopeptide recognition, efflux and/or deactivation.
    Phillips-Jones MK; Harding SE
    Biophys Rev; 2018 Apr; 10(2):347-362. PubMed ID: 29525835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of VanY D,D-carboxypeptidase to glycopeptide resistance in Enterococcus faecalis by hydrolysis of peptidoglycan precursors.
    Arthur M; Depardieu F; Snaith HA; Reynolds PE; Courvalin P
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1899-903. PubMed ID: 7810996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole genome characterization of a naturally occurring vancomycin-dependent Enterococcus faecium from a patient with bacteremia.
    Mitchell SL; Mattei LM; Alby K
    Infect Genet Evol; 2017 Aug; 52():96-99. PubMed ID: 28479127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycopeptide antibiotics and development of inhibitors to overcome vancomycin resistance.
    Gao Y
    Nat Prod Rep; 2002 Feb; 19(1):100-7. PubMed ID: 11902437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.